Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Cash from Financing Activities (2016 - 2025)

InspireMD's Cash from Financing Activities history spans 15 years, with the latest figure at $52.9 million for Q3 2025.

  • For Q3 2025, Cash from Financing Activities rose 5584.56% year-over-year to $52.9 million; the TTM value through Dec 2025 reached $55.6 million, up 9192.47%, while the annual FY2025 figure was $55.6 million, 201.15% up from the prior year.
  • Cash from Financing Activities reached $52.9 million in Q3 2025 per NSPR's latest filing, up from $2.1 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $52.9 million in Q3 2025 to a low of -$965000.0 in Q3 2024.
  • Average Cash from Financing Activities over 4 years is $10.1 million, with a median of $506000.0 recorded in 2025.
  • Peak YoY movement for Cash from Financing Activities: soared 1168833.33% in 2021, then plummeted 194.29% in 2022.
  • A 4-year view of Cash from Financing Activities shows it stood at -$35000.0 in 2021, then tumbled by 194.29% to -$103000.0 in 2022, then soared by 1617.48% to $1.6 million in 2024, then soared by 3286.18% to $52.9 million in 2025.
  • Per Business Quant, the three most recent readings for NSPR's Cash from Financing Activities are $52.9 million (Q3 2025), $2.1 million (Q2 2025), and $506000.0 (Q1 2025).